Quantcast
Last updated on April 21, 2014 at 8:49 EDT

Latest vaginal infections Stories

2013-08-05 12:27:55

Single dose prescription treatment for bacterial vaginosis now available for prescribing ST. LOUIS, Aug. 5, 2013 /PRNewswire/ -- Ther-Rx Corporation, a women's health-focused pharmaceutical company and subsidiary of K-V Pharmaceutical Company (OTCQB Marketplace: KVPHQ/KVPBQ) announced today that Clindesse® (clindamycin phosphate) Vaginal Cream, 2% indicated for the treatment of bacterial vaginosis (BV) in non-pregnant women, is now available for prescribing. Wholesalers have...

2013-04-22 08:29:51

AMSTERDAM, April 22, 2013 /PRNewswire/ -- Dutch Medical Brands receives first European Class IIa Medical Device Status to treat vaginal infections by using cranberry extracts Instead of traditional treatment with antibiotics or chemical substances, vaginal infections can be treated and prevented by using Cranberry-Active tablets, developed by Dutch company Medical Brands. The company has obtained a European Class IIa Medical Device Status for its patented Cranberry-Active...

2013-01-24 08:31:28

ST. LOUIS, Jan. 24, 2013 /PRNewswire/ -- Ther-Rx Corporation, a women's health-focused pharmaceutical company and subsidiary of K-V Pharmaceutical Company (OTCQB Marketplace: KVPHA/KVPHB), and Perrigo Company (Nasdaq: PRGO; TASE) announced today that Gynazole-1® (Butoconazole Nitrate Vaginal Cream USP, 2%), indicated for the local treatment of yeast infections (vulvovaginal candidiasis infections caused by Candida) in non-pregnant women(1), is now available for prescribing. Gynazole-1...